Nephrology News

Holding patient insight as valuable, and thus expanding ways patients can participate in all stages of product development, is essential to ensuring equitable access to emerging dialysis technologies, an expert in patient advocacy said.

A speaker at the virtual Innovations in Dialysis: Expediting Advances Symposium discussed the high incidence of AKI among patients hospitalized with COVID-19 and speculated on why these rates differ across studies.

After searching the Apple App Store and the Google Play Store for all mobile applications focused on dietary management in patients with chronic kidney disease, researchers determined the “few” that exist have important limitations.

Deceased donor AKI, both ongoing and recovery, was associated with higher rates of graft failure following kidney transplantation, a study that determined AKI using a back-estimation of baseline serum creatinine showed.

Greater variability in BMI, as well as fluctuations in other metabolic components, led to an increased risk of mortality, myocardial infarction, stroke and need for dialysis in a cohort of South Korean patients with chronic kidney disease.

Elevated concentrations of serum oxalate were associated with an increased risk for cardiovascular mortality, most notably from sudden cardiac death, according to a post-hoc analysis of the German Diabetes Dialysis Study.

Patients on hemodialysis who survived infection with SARS-CoV-2 developed and maintained antibodies that led to a reduced likelihood of reinfection compared with patients who were not previously infected.

A joint study conducted by the National Kidney Foundation and Labcorp revealed that 80.3% of patients who should have been tested for chronic kidney disease according to clinical practice guidelines did not receive appropriate testing.

Immunocompromised individuals have a number of justifiable concerns surrounding COVID-19. One of those concerns is that a two-dose vaccine schedule may not produce a sufficient antibody response to protect them from the virus.

After finding that patients who received dialysis in-center had higher rates of COVID-19, researchers advocated for “a major shift” to home-based care as a means to reduce the risk for transmission of future infectious diseases.